Canada markets closed

Kaleido Biosciences, Inc. (KLDO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 12:33PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
Total Revenue
1,104
1,104
975
Operating Expenses
Research Development
67,803
67,803
55,967
Selling General and Administrative
20,968
20,968
23,882
Total Operating Expenses
88,771
88,771
79,849
Operating Income or Loss
-87,667
-87,667
-78,874
Interest Expense
2,838
2,838
2,802
Total Other Income/Expenses Net
145
145
-193
Income Before Tax
-90,288
-90,288
-81,620
Income from Continuing Operations
-90,288
-90,288
-81,620
Net Income
-90,288
-90,288
-81,620
Net Income available to common shareholders
-90,288
-90,288
-81,620
Basic EPS
-2.16
-
-2.44
Diluted EPS
-2.16
-
-2.44
Basic Average Shares
41,860
-
33,450
Diluted Average Shares
41,860
-
33,450